Hamilton Thorne Ltd., together with its subsidiary, Hamilton Thorne, Inc., develops, manufactures, and sells precision laser devices and advanced image analysis systems for living cell applications in the fertility, stem cell, and developmental biology research markets. The company offers clinical lasers, such as LYKOS and ZILOS-tk lasers, as well as clinical laser software and hardware for clinical assisted reproduction; and research lasers, including XYRCOS and XYClone lasers for stem cell research, gene targeting, knock out mouse production, SCNT, ICSI, IVF, and assisted hatching applications, as well as Stiletto lasers for isolation of cells of interest, ablation of unwanted cells, and precision scoring of cell colonies. It also provides clinical sperm analysis (CASA) products comprising IVOS II Clinical and CEROS II Clinical, as well as Human Motility II and Dimensions II Strict Morphology software to clinics, hospitals, and assisted reproduction centers; animal and research CASA systems, and motility software packages; and various sperm analyzer options. In addition, the company offers sperm analysis accessories, such as accu-beads+ for use in counting procedures in semen analysis; 2X-CEL disposable semen analysis slides; IDENT Stains for determining sperm motility and concentration; VIADENT stain to determine viable sperm count, concentration, and percentage from a motile sample; and MiniTherm Stage Warmer for CASA and manual sperm motility analysis. Further, it offers IMSI-Strict, an automated software solution for live sperm morphology under high magnification; Oosight imaging system for research purposes; and CIVA, a custom software to capture images/video and annotate. The company sells its products to pharmaceutical and biotechnology companies, fertility clinics, university research centers, and other commercial and academic research establishments worldwide. Hamilton Thorne Ltd. is based in Beverly, Massachusetts.
Industry, Sector and Symbol
Industry Medical Devices
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone+1-978-9212050
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesC$30.55 million
Profitability
Miscellaneous
EmployeesN/A
Next Earnings Date11/21/2019 (Confirmed)
OptionableNot Optionable
Hamilton Thorne (CVE:HTL) Frequently Asked Questions
What is Hamilton Thorne's stock symbol?
Hamilton Thorne trades on the Canadian Venture Exchange (CVE) under the ticker symbol "HTL."
When is Hamilton Thorne's next earnings date?
What price target have analysts set for HTL?
2 brokerages have issued 1 year price objectives for Hamilton Thorne's stock. Their forecasts range from C$1.30 to C$1.30. On average, they expect Hamilton Thorne's stock price to reach C$1.30 in the next twelve months. This suggests a possible upside of 32.7% from the stock's current price. View Analyst Price Targets for Hamilton Thorne.
What is the consensus analysts' recommendation for Hamilton Thorne?
2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Hamilton Thorne in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Hamilton Thorne.
Has Hamilton Thorne been receiving favorable news coverage?
Press coverage about HTL stock has trended very negative on Monday, InfoTrie Sentiment reports. The research firm ranks the sentiment of news coverage by analyzing more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. Hamilton Thorne earned a media sentiment score of -3.0 on InfoTrie's scale. They also gave press coverage about the company a news buzz of 4.0 out of 10, meaning that recent news coverage is somewhat unlikely to have an effect on the stock's share price in the near future. View News Stories for Hamilton Thorne.
Who are some of Hamilton Thorne's key competitors?
Some companies that are related to Hamilton Thorne include Draegerwerk AG & Co KGaA (DRW3), Zynex (ZYXI), Creo Medical Group (CREO), Medica Group (MGP), Cyclopharm (CYC), Advanced Oncotherapy (AVO), Impedimed (IPD), REVA Medical (RVA), Kromek Group (KMK), Electromed (ELMD), Helius Medical Technologies (HSM), MRI Interventions (MRIC), Protech Home Medical (PHM), EMvision Medical Devices (EMV) and Oventus Medical (OVN).
What other stocks do shareholders of Hamilton Thorne own?
Who are Hamilton Thorne's key executives?
Hamilton Thorne's management team includes the folowing people:
- Ms. Meg Spencer, Co-Founder & Chairman
- Mr. David B. Wolf, Pres, CEO & Director
- Mr. Diarmaid H. Douglas-Hamilton, Co-Founder, Sr. VP of R&D, CTO, Corp. Sec. and Director
- Mr. Michael W. Bruns, VP of Fin. & CFO (Age 62)
- Dr. Fabian Sell, Chief Exec. Officer of Gynemed
How do I buy shares of Hamilton Thorne?
Shares of HTL and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is Hamilton Thorne's stock price today?
One share of HTL stock can currently be purchased for approximately C$0.98.
How big of a company is Hamilton Thorne?
What is Hamilton Thorne's official website?
How can I contact Hamilton Thorne?
Hamilton Thorne's mailing address is 100 Cummings Ctr Ste 465e, BEVERLY, MA 01915-6143, United States. The company can be reached via phone at +1-978-9212050.
MarketBeat Community Rating for Hamilton Thorne (CVE HTL)
MarketBeat's community ratings are surveys of what our community members think about Hamilton Thorne and other stocks. Vote "Outperform" if you believe HTL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe HTL will underperform the S&P 500 over the long term. You may vote once every thirty days.
